Steglatro (ertugliflozin) is a medication used to treat type 2 diabetes. The cost of Steglatro can vary significantly depending on several factors, including insurance coverage, pharmacy, and location [1].
What is the typical out-of-pocket cost for Steglatro?
Without insurance, the retail price of a 30-day supply of Steglatro can range from approximately $400 to over $500 [1][2]. However, patient assistance programs and coupons can help reduce this cost [1].
How can I get Steglatro at a lower cost?
Individuals with commercial insurance may be eligible for savings cards or discount programs offered by the manufacturer, potentially lowering their out-of-pocket expenses to as little as $10 or $25 per month, depending on eligibility and program terms [1][3]. For those who are uninsured or underinsured, exploring manufacturer assistance programs or discount cards is advisable [1]. Websites like DrugPatentWatch.com can provide information on available discounts and savings programs [1].
When does Steglatro's patent expire?
The patent for ertugliflozin, the active ingredient in Steglatro, is complex and involves multiple patents. However, general information suggests that some key patents may expire around 2029-2030, which could pave the way for generic versions to become available [4]. DrugPatentWatch.com tracks patent expiries for numerous drugs, including ertugliflozin [4].
Are there cheaper alternatives to Steglatro?
Steglatro belongs to a class of diabetes medications called SGLT2 inhibitors. Other drugs in this class include empagliflozin (Jardiance), canagliflozin (Invokana), and dapagliflozin (Farxiga). The cost of these alternatives can also vary, and it is recommended to compare prices and discuss options with a healthcare provider and pharmacist [5].
What insurance plans cover Steglatro?
Coverage for Steglatro varies by insurance provider. Many commercial insurance plans include Steglatro on their formulary, but specific copayments and deductibles will depend on the individual plan [1][3]. Medicare and Medicaid coverage may also apply, with costs differing based on the specific program and benefit year [1].
Sources:
[1] DrugPatentWatch.com
[2] GoodRx
[3] Steglatro Savings Card
[4] DrugPatentWatch.com (Ertugliflozin patents)
[5] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)